Contact HealthDay
Tel: 203.855.1400 or E-mail

News By Specialty

Allergy
Anesthesiology
Cardiology
Cosmetic Surgery
Critical Care
Dermatology
Diabetes & Endocrinology
Emergency Medicine
Family Practice
Gastroenterology
Geriatrics
Hematology & Oncology
HIV & AIDS
Infectious Disease
Internal Medicine
Nephrology
Neurology
Nursing
OBGYN & Women's Health
Ophthalmology
Orthopedics
Otolaryngology
Pain Management
Pathology
Pediatrics
Pharmacy
Psychiatry
Pulmonology
Radiology
Rheumatology
Surgery
Urology

Follow us on:

    


e-Healthcare Leadership Awards


Immune Intervention Reduces β-Cell Death in Type 1 Diabetes
Improvement in C-peptide responses seen with teplizumab; associated with decreased β-cell death
This article is older than one year and is no longer available.

Copyright © 2013 HealthDay. All rights reserved.

January 30, 2015

Archive Search

By Keyword:
By Category:
By Topic:

Related Articles

CDC: ~8 Percent of U.S. Adults Nonadherent Due to Rx Costs

PCBs, Phthalates Linked to Earlier Menopause

Triglycerides Significantly Elevated in Women With GDM

Benefits Package Important for Attracting, Retaining Staff

Women With PCOS Hospitalized More Often

How Does DPP-4 Inhibition Affect Liver Function?